Loading clinical trials...

Adjuvant Use of Neostigmine in Sepsis and Septic Shock. | Clinical Trials | Clareo Health

COMPLETEDPhase 2NCT04130230

Adjuvant Use of Neostigmine in Sepsis and Septic Shock.

The inflammatory response represents an important, central component of sepsis. Therefore, it is believed that blunting inflammation will decrease mortality. In vivo test series with mice that had und...

Lead sponsor: Mansoura University•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Related studies

Not Yet Recruiting

Multicenter Symphony™ IL-6 Monitoring Sepsis ED Pilot Study

NCT07425587 · Sepsis, Septic Shock

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: July 10, 2024Terms

Trial snapshot

StatusCOMPLETED

PhasePHASE2

Enrollment50

Start dateMar 2019

Last updatedJul 10, 2024

Condition

Sepsis, Septic Shock

Locations shown

Tanta University Hospital

Tanta, EL-Gharbia

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: July 10, 2024Data synced to Clareo: May 10, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions